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Abstract
Aging-associated ependymal-cell pathologies can manifest as ventricular gliosis, ventricle enlarge-
ment, or ventricle stenosis. Ventricle stenosis and fusion of the lateral ventricle (LV) walls is
associated with a massive decline of the proliferative capacities of the stem cell niche in the
affected subventricular zone (SVZ) in aging mice. We examined the brains of adult C57BL/6 mice
and found that ependymal cells located in the adhesions of the medial and lateral walls of the
rostral LVs upregulated parvalbumin (PV) and displayed reactive phenotype, similarly to injury-
reactive ependymal cells. However, PV1 ependymal cells in the LV-wall adhesions, unlike injury-
reactive ones, did not express glial fibrillary acidic protein. S100B1/PV1 ependymal cells found in
younger mice diminished in the LV-wall adhesions throughout aging. We found that periventricular
PV-immunofluorescence showed positive correlation to the grade of LV stenosis in nonaged mice
(<10-month-old), and that the extent of LV-wall adhesions and LV stenosis was significantly lower
in mid-aged (>10-month-old) PV-knock out (PV-KO) mice. This suggests an involvement of PV1
ependymal cells in aging-associated ventricle stenosis. Additionally, we observed a time-shift in
microglial activation in the LV-wall adhesions between age-grouped PV-KO and wild-type mice,
suggesting a delay in microglial activation when PV is absent from ependymal cells. Our findings
implicate that compromised ependymal cells of the adhering ependymal layers upregulate PV and
display phenotype shift to “reactive” ependymal cells in aging-related ventricle stenosis; moreover,
they also contribute to the progression of LV-wall fusion associated with a decline of the affected
SVZ-stem cell niche in aged mice.
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1 | INTRODUCTION
In a previous article, we described the injury-triggered upregulation of
the EF-hand calcium-binding protein parvalbumin (PV) in ependymal
cells of the lateral ventricle (LV) (Szabolcsi & Celio, 2015). This study
investigates the effects of aging on ependymal cells and the ependymal-
cell responses in aging-associated ventricle stenosis known for its delete-
rious effects on adult neurogenesis in old mice.
Adult neurogenesis takes place in two regions of the mammalian
brain: in the subgranular zone of the dentate gyrus (Kaplan & Hinds,
1977) and in the subventricular zone (SVZ) along the lateral wall of the
rostral LV (Lois & Alvarez-Buylla, 1994). The SVZ supports neurogene-
sis by continuously generating new neurons that migrate to the olfac-
tory bulb via the rostral migratory stream (Doetsch & Alvarez-Buylla,
1996). The SVZ is a neurogenic stem cell niche with a unique microen-
vironment consisting not only of neural stem cells (NSCs) but support
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cells and blood vessels. The ventricle surface in the adult neurogenic
niche is organized in pinwheels with centrally located NSCs that con-
tact the ventricle via apical processes, surrounded by ependymal cells
(Mirzadeh, Merkle, Soriano-Navarro, Garcia-Verdugo, & Alvarez-Buylla,
2008). SVZ-supported neurogenesis has been shown to considerably
decrease with aging (Tropepe, Craig, Morshead, & van der Kooy, 1997),
and this decline is in part due to a reduction in epidermal growth factor
receptor signaling (Enwere et al., 2004), but other factors are likely
involved, too. The morphological changes in the aging SVZ involve a
reduction in the number of pinwheels, of NSCs per pinwheel, and of
ventricle-containing apical processes of the NSCs (Shook, Manz, Peters,
Kang, & Conover, 2012). One unique characteristic of aging is ventral
stenosis of the LV walls, which is formed by adhesion and later on
fusion of the medial and lateral LV walls, causing the deterioration of
the affected SVZ, therefore most of the ventral neurogenic SVZ (Luo,
Daniels, Lennington, Notti, & Conover, 2006; Shook et al., 2012). As a
result of this, and/or additional age-associated alterations, the rest of
the ventricular cavity expands; causing a thinning of the remaining
ependymal cell layer (Conover & Shook, 2011).
The ventricular system is lined with ependymal cells that form a
cell monolayer, facilitate the circulation of cerebrospinal fluid (CSF)
and participate in the metabolic exchange between CSF and brain
parenchyma (Del Bigio, 2010). Ependymal cells in the brain, unlike
other epithelial linings, display inadequate regeneration following lesion
since they are unable to generate progeny required for the replace-
ment of cell loss (Spassky et al., 2005). A form of SVZ-mediated epen-
dyma repair throughout aging is retained by astrocytes that integrate in
the ependymal layer and take on morphological features of ependymal
cells (Luo, Shook, Daniels, & Conover, 2008). Other studies revealed
that in the neurogenic SVZ stem cell niche, the two main niche cell
types, ependymal cells, and astrocytes retained a high level of plasticity:
in response to lesion, astrocytes gave rise to ependymal cells and epen-
dymal cells gave rise to niche astrocytes (Nomura, Goritz, Catchpole,
Henkemeyer, & Frisen, 2010). Recently, we have found an alternative
mechanism of ependymal-cell response to injury: ependymocytes
following mechanical lesion acquired reactive phenotype, enhanced
cell motility and wound-closure capacity upon injury-induced PV-
upregulation (Szabolcsi & Celio, 2015).
Ependymal-cell pathologies involve a wide variety of diseases and
conditions ranging from genetic disorders resulting in hydrocephalus
(Del Bigio, 2010), declined adult neurogenesis via loss of planar cell
polarity (Sawamoto et al., 2006) or ankyrin 3 (Ank3) (Paez-Gonzalez
et al., 2011), and impaired barrier function leading to leukocyte infiltra-
tion into the ventricles in infectious and inflammatory conditions
(Alvarez & Teale, 2007). Because of the restricted regenerative capacity
of ependymal cells, deleterious impulses that compromise the ependy-
mal layer often result in irreversible loss of ependymal integrity, a
phenomenon that occurs throughout aging both in human and mice
(Shook et al., 2013). Aging-related ependymal cell loss implies ventricu-
lar surface gliosis and consequent ventricle enlargement—a condition
often observed in elderly humans (Shook et al., 2013), revealing the
importance of maintaining an intact ependymal cell lining throughout
aging.
During the course of ventricle stenosis, the ependymal layer is
essentially intact in the adhered LV walls in 3-month-old mice, but
deteriorates throughout aging as fusion progresses, leaving 1-year-old
mice without ependymal cells in the fused regions (Shook et al., 2012).
Most importantly, SVZ-supported neurogenesis is also absent in fused
LV walls lacking ependymal cells, thereby extensive LV-wall fusions
contribute fundamentally to the aging-related decline of SVZ-supported
neurogenesis (Shook et al., 2012). Despite its impact, the molecular and
cellular players underlying the progression of LV-wall fusion are so far
unknown.
This study was undertaken to learn more about the role ependymal
cells play in the progression of aging-related LV-wall fusion and ventricle
stenosis and to determine what role ependymal PV-expression might
play in this process.
2 | MATERIALS AND METHODS
2.1 | Mice
C57BL/6 (Janvier, Lyon, France), Parvalbumin-Cre::loxP-DsRed-loxP-
enhanced green fluorescent protein (eGFP) (hereafter: PV-Cre/eGFP),
PV-KO, PV-KO-eGFP, and Foxj1-eGFP mice (Jackson Laboratory, Bar
Harbor, ME) were used in this study. Mice that express Cre under the
Pvalb promoter were crossed with a double-fluorescent, Cre-reporter
strain [B6;C3-Tg(CAG-DsRed,-EGFP)5Gae/J; Jackson Laboratory,
Sacramento, CA], which has a general expression of a loxP-flanked red
fluorescent protein variant (DsRed-Express) prior to Cre recombinase
exposure, and eGFP following Cre-mediated recombination. In the off-
spring, the DsRed-Express cassette is deleted in the PV-expressing
cells, allowing expression of the eGFP cassette located downstream.
PV-KO-eGFP mice were generated by crossing a PV-eGFP mouse
strain (B6.Tg(Pvalb-EGFP)1Hmon) to a PV-KO one (B6.Pvalbtm1S-
walXB6Tg(Pvalb-EGFP)1Hmon) (Schwaller et al., 1999). Foxj1-eGFP
mice [(B6;C3-Tg(FOXJ1-EGFP)85Leo/J, Jackson Laboratory, Sacra-
mento, CA] express eGFP under the control of the human forkhead
box J1 (Foxj1) gene promoter, a transcription factor known as the mas-
ter regulator of motile ciliogenesis (Ostrowski, Hutchins, Zakel, &
O’Neal, 2003). In the murine brain, Foxj1-expression is restricted to
ependymal cells and a subset of astrocytes in the adult stem cell
niche in the SVZ (Jacquet et al., 2009). All animal experiments were
performed according to institutional guidelines and with the permission
of the cantonal committee on animal experimentation (Permission No:
2016_03_FR).
2.2 | Immunofluorescence
Adult C57BL/6 (n515), PV-Cre/eGFP (n56), Foxj1-eGFP (n58),
PV-KO (n518), and PV-KO-eGFP (n55) mice (4- to 15-month-old,
of both sexes) were transcardially perfused with a solution of 4%
paraformaldehyde (PFA) in 0.1M phosphate-based saline (PBS, pH 7.4).
The brains were removed and post-fixed in 4% PFA in PBS overnight
at 48C, followed by incubation overnight in a cryoprotectant solution
(18% saccharose in Tris-based saline [TBS]), and processed for cutting
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40-mm-thick coronal sections with a freezing microtome (Frigomobil,
Reichert-Jung, Vienna, Austria). Immunofluorescence was performed
on free-floating sections with the following antibodies and antisera
(Table 1): rabbit anti-PV (diluted 1:1,000, Swant, Marly, Switzerland,
Cat. #PV 25, RRID:AB_10000344), guinea pig anti-PV (diluted 1:1,000,
Swant, Marly, Switzerland, Cat. #GP72, RRID:AB_2665495), rabbit
anti-S100B (diluted 1:1,000, Swant, Marly, Switzerland, Cat. #37,
RRID:AB_2315304), guinea pig anti-S100B (diluted 1:500, Synaptic
Systems, G€ottingen, Germany, Cat. #287 004, RRID:AB_2620025),
mouse anti-glial fibrillary acidic protein (GFAP) (diluted 1 mg/ml, Novus
Biologicals, Cambridge, UK, Cat. #NBP1–05197, RRID:AB_1555288),
rabbit anti-GFP (diluted 1 mg/ml, Molecular Probes, Thermo Fisher
Scientific, Reinach, Switzerland, Cat. #A-11122, RRID:AB_221569),
mouse anti-GFP (diluted 0.1 mg/ml, Molecular Probes, Thermo Fisher
Scientific, Reinach, Switzerland, Cat. #A-11120, RRID:AB_221568), and
rabbit anti-Iba1 (diluted 1 mg/ml, Wako, Neuss, Germany, Cat. #019–
19741, RRID:AB_839504). Primary antibodies were diluted in 0.1M
TBS pH 7.3 with 0.1% Triton X-100 and 10% bovine serum and incu-
bated overnight at 48C. Primary antibody staining was revealed using
species-specific fluorophore-conjugated secondary antibodies (Cy3,
Alexa Fluor 488 and Alexa Fluor 647, Jackson Immuno Research/Milan
Analytica, Rheinfelden, Switzerland). Cy3, Alexa Fluor 488 and Alexa
Fluor 647-conjugated secondary antibodies were diluted in 0.1M TRIS
pH 8.2 at 4 mg/ml working concentration and incubated for 3 hr at
room temperature. To exclude nonspecific labeling or high degrees of
autofluorescence in the samples, free-floating coronal sections—encom-
passing regions of LV-wall adhesions—incubated only with secondary
antibodies were used as negative controls. Nuclear counterstaining was
performed by incubation with 40,6-diamidino-2-phenylindole (DAPI,
Molecular Probes, LuBioScience, Lucerne, Switzerland) diluted in 0.1M
PBS pH 7.4 at 10 mg/ml working concentration for 30 min at room tem-
perature. Between incubation steps, 3 3 5 min thorough washes in
0.1M TBS pH 7.3 were applied. Immunostained sections were mounted
on Superfrost Plus slides (Thermo Fisher Scientific, Reinach,
Switzerland), air-dried at 378C for 30 min, and covered with standard
thickness (No. 1) 24 3 60 mm cover slips (Gribi AG, Belp, Switzerland)
with aqueous nonfluorescent mounting medium (Hydromount by
National Diagnostics, Chemie Brunschwig AG, Basel, Switzerland).
2.3 | Characterization of the antibodies and antisera
We confirmed the specificity of the antibodies and antisera used in this
study by Western blotting. Brains from adult C57Bl/6 and PV-KO and
muscle tissue from PV-eGFP euthanized mice were quickly removed,
homogenized and soluble proteins were extracted for Western blotting
experiments. Proteins (50 mg for brain and muscle lysates) were
separated by sodium dodecyl suflate polyacrylamid geleletrophoresis
(SDS-PAGE) (12%). After electrophoresis, the proteins were transferred
on nitrocellulose membranes (MS solution, Chemie Brunschwig, Basel,
Switzerland). The membranes were then blocked in 5% nonfat milk in
TBS-T for 20 min at room temperature and incubated with primary
antibodies as listed in Table 1 in 2% nonfat milk in TBS-T overnight at
48C. Membranes were washed three times in TBS-T and incubated for
1 hr with secondary antibodies: horseradish peroxidase (HRP) conju-
gated goat anti-rabbit IgG 1:10,000, HRP conjugated goat anti-mouse
IgG 1:5,000 (Sigma-Aldrich, Buchs, Switzerland) or HRP conjugated
donkey anti-guinea pig IgG 1:5,000 (Jackson Immuno Research/Milan
Analytica, Rheinfelden, Switzerland) in TBS-T. Finally, membranes were
repeatedly rinsed in TBS and developed using enhanced chemilumines-
cence (ECL) (Merck Millipore, Schaffhausen, Switzerland). Bands were
visualized using FluorChem E (San Jose, CA). Additionally, we confirmed
the staining patterns of each antibody and antiserum (Table 1) on coro-
nal brain sections throughout the whole brain by immunofluorescence
as described above.
The polyclonal guinea pig PV antiserum was raised against
recombinant mouse PV. The polyclonal rabbit PV antiserum was raised
against recombinant rat PV. In Western blot, a single band at the
molecular weight level of PV (12 kDa) was detected by both rabbit
TABLE 1 List of the antibodies and antisera used in this study
Name Immunogen Manufacturer, Cat. no., RRID Species Clonality
Dilution
for IF
Dilution
for WB
anti-PV Recombinant mouse parvalbumin Swant, GP72, RRID:AB_2665495 Guinea-pig Polyclonal 1:1,000 1:5,000
anti-PV Recombinant rat parvalbumin Swant, PV 25, RRID:AB_10000344 Rabbit Polyclonal 1:1,000 1:5,000
anti-GFAP
(5C10)
Purified pig spinal cord GFAP Novus Biologicals, NBP1–05197,
RRID:AB_1555288
Mouse Monoclonal 1:1,000 1:1,000
anti-S100B Purified bovine brain S100B Swant, 37, RRID:AB_2315304 Rabbit Polyclonal 1:1,000 1:1,000
anti-S100B Recombinant full length rat S100B Synaptic Systems, 287 004,
RRID:AB_2620025
Guinea-pig Polyclonal 1:500 1:1,000
anti-Iba1 Synthetic peptide corresponding
to C-terminus of Iba1
WAKO, 019–19741,
RRID:AB_839504
Rabbit Polyclonal 1:1,000 1:1,000
anti-GFP Jellyfish A. victoria GFP Thermo Fisher Scientific, A-11122,
RRID:AB_221569
Rabbit Polyclonal 1:2,000 1:5,000
anti-GFP Jellyfish A. victoria GFP Thermo Fisher Scientific, A-11120,
RRID:AB_221568
Mouse Monoclonal 1:2,000 1:2,000
IF5 immunofluorescence; WB5Western blot
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and guinea pig anti-PV antibodies in brain extracts form wild-type
(WT) animals while no signal was detected in extracts from PV-KO
mice (Figure 1a,b). Pure mouse recombinant calretinin and calbindin
proteins were used as additional negative controls, and pure mouse
recombinant PV protein as positive control (Figure 1a,b). Known
amount of pure mouse recombinant PV protein was loaded on the
same blot used as reference protein (normalization control). The rela-
tive affinity of anti-PV antibodies in each sample (n53 for PV 25 and
FIGURE 1.
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n53 for GP72) was determined by calculating the ratio of the intensity
of the signal for PV to that of the normalization control. Both the rabbit
and guinea pig anti-PV antibodies showed similar affinity for the target
protein (8.04%63.8 for GP72 and 7.6%63 for PV 25, p5 .885).
Additionally, we calculated the ratios of the intensity of the signal for
the recombinant protein. Both anti-PV antibodies showed similar affin-
ity for the pure recombinant PV protein. We also confirmed by immu-
nofluorescence that the staining patterns of both anti-PV antibodies
were identical in different brain areas regarding cellular morphology
and distribution and consistent with that of PV-interneurons (Figure
1a,b) as demonstrated previously (Filice, Vorckel, Sungur, Wohr, &
Schwaller, 2016; Xu, Roby, & Callaway, 2010). These results confirm
the specificity of the anti-PV antibodies.
The monoclonal anti-GFAP antibody was raised against purified
pig spinal cord GFAP. We tested the antibody by immunofluorescence
on murine coronal brain sections and confirmed that the pattern of
staining regarding cellular morphology and distribution in the brain was
consistent with that of astrocytes (Figure 1c) as demonstrated in previ-
ous studies (Sofroniew & Vinters, 2010). This antibody was shown to
label astrocytes in previous studies as well (Brai et al., 2014; Szabolcsi
& Celio, 2015). In Western blot, the antibody detected a single band at
about 50 kDa—corresponding to the major isoform of GFAP—in murine
brain protein extract (Figure 1f), whereas no signal was detected in
muscle protein extract (negative control).
The polyclonal rabbit S100B antiserum was raised against purified
bovine brain S100B. We confirmed that the staining pattern through-
out the brain regarding cellular morphology and distribution corre-
sponds to astrocytes and ependymal cells (Figure 1d) as demonstrated
in previous studies (Raponi et al., 2007; Spassky et al., 2005). In West-
ern blot, the antiserum detected a prominent band at about 10 kDa—
corresponding to the expected molecular weight of S100B—in mouse
brain protein extract, whereas no signal was detected in muscle protein
extract (Figure 1g). The S100B antiserum was used to label ependymal
cells in murine brain sections and organotypic slice cultures in our pre-
vious study (Szabolcsi & Celio, 2015). Previous studies showed that in
Western blot analysis of gerbil brain lysate, the S100B antiserum rec-
ognized the expected band at about 10 kDa (Ford, Grothe, & Klug,
2009).
The polyclonal guinea pig S100B antiserum was raised against
recombinant full length rat S100B. We tested the specificity of the anti-
serum by comparing the staining pattern with that of the polyclonal rab-
bit S100B antiserum on coronal murine brain sections throughout the
entire brain.We confirmed that the staining patterns were identical (Fig-
ure 1d). In Western blot, the antiserum detected a prominent band at
the expected molecular weight 10 kDa in murine brain protein extract,
while no signal was detected in muscle protein extract (Figure 1h).
The purified polyclonal rabbit Iba1 antiserum was raised against a
synthetic peptide corresponding to the C-terminus of Iba1. We con-
firmed by immunofluorescence that the staining pattern of the Iba1
antiserum in the brain regarding cell morphology and distribution is
consistent with that of microglial cells (Figure 1e) as demonstrated in
previous studies (Ito et al., 1998). In Western blot, the antiserum
detected the expected band at about 17 kDa corresponding to the
molecular weight of Iba1 (Figure 1i). This Iba1 antibody was shown to
label murine microglial cells in previous studies as well (Bosco, Steele,
& Vetter, 2011; Petkau et al., 2010).
The polyclonal rabbit GFP antiserum was raised against GFP pro-
tein isolated from the jellyfish Aequorea victoria. We previously con-
firmed the immunofluorescence specificity by comparing the staining
pattern with the eGFP-expression pattern in Foxj1-eGFP and PV-KO-
eGFP organotypic hippocampal slice cultures (Szabolcsi & Celio, 2015).
In Western blot, the antibody detected a single band at about 30 kDa
in PV-eGFP muscle protein extract corresponding to the expected
molecular weight of GFP, while no signal was detected in the WT brain
FIGURE 1 Characterization of the antibodies and antisera. We confirmed the specificity of the antibodies and antisera used in this study
by Western blotting, respectively by analyzing the immunofluorescence staining patterns. Confocal z-stack overprojections in the regions of
the cingulate cortex and reticular thalamic nucleus (RTN) depict PV-immunopositive neurons stained with rabbit anti-PV (PV 25, Swant) (a)
and with guinea pig anti-PV (GP72, Swant) (b) antibodies. The staining patterns of the two anti-PV antibodies are comparable. Whole brain
protein extracts from adult C57Bl/6 and PV-KO mice were separated by SDS-PAGE and transferred on nitrocellulose membranes. After
blocking, the membranes were incubated with rabbit anti-PV (a) and guinea pig anti-PV (b) antibodies. Pure recombinant calretinin (CR) and
calbindin (CB) proteins were used as additional negative controls, and pure recombinant parvalbumin (PV) protein as positive control. A sin-
gle band at the expected molecular weight of PV (12 kDa) was detected by both antibodies in brain extracts form wild-type (WT) animals,
while no signal was detected in extracts from PV-KO mice (a, b). Pure recombinant PV tends to form dimers in solution, which were also
detected by both antibodies at about 24 kDa in addition to the expected 12 kDa signal (a, b). Confocal z-stack overprojections depict
GFAP-immunostained astrocytes in the corpus callosum, hippocampus and internal capsule (c), S100B-immunostained astrocytes in the cin-
gulate cortex and striatum, respectively ependymal cells in the lateral ventricle (LV) walls (d), and Iba1-immunostained microglia in the cin-
gulate cortex, striatum, and internal capsule (e). Coronal sections incubated with secondary antibodies without previous incubation with
primary antibodies were used as negative controls. The staining pattern of the mouse anti-GFAP antibody (Novus Biologicals) is consistent
with that of astrocytes (c). The rabbit anti-S100B (Swant) and the guinea pig anti-S100B (Synaptic Systems) staining patterns appear compa-
rable (d). The Iba1-immunostaining pattern is consistent with that of microglia (e). In Western blot analysis, the mouse anti-GFAP detects
the expected band at about 50 kDa in the murine brain and gives no signal in the muscle protein extract (f). The rabbit anti-S100B detects
a prominent band at about 10 kDa in the murine brain protein extract, while no signal is detected in muscle protein extract (g). Similarly,
the guinea pig anti-S100B detects a prominent band at about 10 kDa in the murine brain protein extract, and no signal in the muscle pro-
tein extract (h). The anti-Iba1 detects the expected band at about 17 kDa in the murine brain lysate, with no signal detected in the muscle
extract (i). Both the rabbit anti-GFP (j) and mouse anti-GFP (k) antibodies recognize the expected band about 30 kDa in the PV-eGFP mus-
cle protein extract, while they detect no signal in the WT brain protein extracts. GP5 guinea pig; Ms5mouse; Rb5 rabbit
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protein extract (Figure 1j). In previous studies, the antibody was shown
to detect a single band in Western blot analysis of whole-cell lysates
from GFP-transfected normal human epidermal keratinocytes (NHEK)
cells, and was negative in untransfected cells (Hiroyasu et al., 2013).
The monoclonal anti-GFP antibody was raised against GFP protein
isolated from the jellyfish A. victoria. We tested the immunofluores-
cence specificity by confirming that the staining pattern coincided with
the eGFP-expression in Foxj1-eGFP, respectively in PV-KO-eGFP orga-
notypic hippocampal slice cultures (Szabolcsi & Celio, 2015) and in cor-
onal brain sections derived from Glycine transporter 2 (GlyT2)-eGFP
mice (Szabolcsi, Albisetti, & Celio, 2017). In Western blot, the antibody
detected a single band at about 30 kDa in PV-eGFP muscle protein
extract corresponding to the expected molecular weight, while no
signal was detected in the WT brain protein extract (Figure 1k).
FIGURE 2.
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2.4 | Stereological volume estimation
Forty-micrometer-thick coronal sections of C57BL/6 (n513) and PV-
KO (n518) mice were collected consecutively, maintaining a rostro-
caudal order. Sections encompassing the region of the rostral LVs were
immunostained with anti-S100B, anti-PV and anti-GFAP antibodies,
and counterstained with DAPI. A systematic random sampling (SRS)
series was generated by randomly choosing section number 1 out of
the 3 consecutive sections following section “zero.” Section “zero” was
defined as the first section where the LVs rostrally appear, usually cor-
responding approximately to Bregma level 11.5 mm. Every 6th section
starting from section no. 1 were mounted until ca. Bregma level
0.0 mm, thus resulting in a series of six coronal sections encompassing
approximately a 1.5 mm length along the sagittal axis of the rostral por-
tion of the LVs. The series of sections were analyzed with a stereology
workstation consisting of a Zeiss Axioplan microscope (Carl Zeiss AG,
Feldbach, Switzerland) equipped with Stereo Investigator software
(MBF Bioscience, Magdeburg, Germany, RRID:SCR_002526). The vol-
ume of the LVs and of the LV-wall adhesions were determined accord-
ing to the Cavalieri principle (Gundersen & Jensen, 1987) applying the
Cavalieri Estimator Probe. A grid spacing of 50 mm was used for the
volume estimation of the LV volume, respectively a grid spacing of 20
mm for the volume estimation of the LV-wall adhesions.
2.5 | In vivo stereotactic lesion of the LV walls
Adult (4- to 5-month-old) Foxj1-eGFP mice (n53) were anesthetized
with a solution of Ketamine/Xylazine (100 mg/kg and 10 mg/kg body
weight, respectively) dissolved in 0.9% NaCl solution and their heads
were restrained in a stereotactic apparatus (Kopf Instruments, Tujunga,
CA). The lesion was carried out unilaterally over the left LV with a 1-mm-
long-blade. The stereotactic coordinates of the lesion were mediolaterally
12.5 mm, rostrocaudally between Bregma 21.0 and 22.0 mm, depth
from skull surface 3 mm. Lesioned mice were transcardially perfused with
a 4% PFA solution in 0.1 M PBS (pH 7.4) 1 week after the injury, the
brains were post-fixed overnight at 48C, transferred to cryoprotectant
solution (18% saccharose) and processed for cutting 40-mm-thick-
sections with a freezing microtome (Frigomobil, Reichert-Jung, Vienna,
Austria). Immunofluorescence on free-floating sections was performed
with anti-GFP, anti-PV, and anti-GFAP antibodies.
2.6 | Imaging
Coronal brain sections were imaged by a Nanozoomer 2.0-HT digital
slide scanner (Hamamatsu Photonics France, Massy, France), a Leica
TCS SP5 confocal laser scanning microscope, and a Leica DM 6000B
fluorescence microscope (Leica, Germany). Confocal z-stacks were
superposed in maximum intensity projections using ImageJ (Fiji, RRID:
SCR_002285), or are presented as thin layer reconstructions. Thin layer
reconstructions were performed by maximum intensity projection of
only few z-planes by ImageJ, resulting in 3–5 mm thin optical sections.
The entire image sequences of raw confocal z-stacks from Figures 2–3,
and 7, respectively of the negative controls are available as an open
access data set on Zenodo (http://doi.org/10.5281/zenodo.437943).
Image post-processing was limited to contrast adjustment only and
was done by ImageJ.
2.7 | Image acquisition by confocal microscopy
The Leica TCS SP5 confocal laser scanning microscope system used for
fluorescence intensity measurement was equipped with an inverted
Leica DMI 6000 stand with motorized stage, conventional galvo scan-
ner, four lasers: diode laser (405 nm), Argon laser (458, 477, 488, 496,
and 514 nm), diode pumped solid state laser (561 nm), and Helium-
Neon laser (HeNe, 633 nm), Acousto-Optical Beam Splitter as tunable
dichroic for all lasers, and three photomultiplier tube detectors with
spectral detection. Regular instrument calibration and adjustment was
performed according to the guidelines of the manufacturer. Confocal z-
stacks were acquired with a Leica HC PL APO CS2 40.0x 1.30 OIL UV
objective (numeric aperture: 1.30, magnification: 40.03, corrections
CS, UV, apochromatic (APO), refraction index: 1.52), pinhole was set to
68.3 mm (airy 1.05), z-step size to 0.42 mm. No frame or line accumula-
tion, respectively averaging was used. The parameters of image acquisi-
tion (laser and acousto-optic tunable filter (AOTF) intensity, gain,
FIGURE 2 Nonaged (4-month-old) C57BL/6 mice exhibit unilateral ventricle stenosis and PV-immunopositive ependymal cells in the adher-
ing ependymal layers. Confocal laser z-stack overprojections depict the nonadhering LV walls (a) and the adhering ones on the contralateral
side (b). Immunofluorescence for S100B revealed a uniform staining of the ependymal layers in the nonadhering LV walls (a), whereas a
continuous S100B-stained ependyma was lacking in the LV-wall adhesion (b). Instead, patches of S100B-positive ependymal cells could be
observed in the adhesion zone (b, arrows). PV-immunostaining was found in S100B-immunopositive ependymal cells (d), whereas it was vir-
tually absent from the normal, nonadhering LV walls (c). Approximately 5-mm-thick thin layer reconstruction of few z-planes shows co-
expression of S100B and PV-immunofluorescence in the same cells in the LV-wall adhesions (d1). GFAP-immunostaining on the same sec-
tions revealed several GFAP-stained astrocytic processes intermingled in the PV1 ependymal-cell clusters of the LV-wall adhesions (f), as
well as in the normal, nonadhering ependymal layer on the contralateral side (e). In thin layer reconstruction of few z-planes, no co-labeling
between GFAP- and PV-staining was observed (f1). We examined the LV walls of 8-month-old Foxj1-eGFP mice, which display transgenic
eGFP-expression in ependymal cells. Confocal z-stack overprojections of nonadhering LV walls depict eGFP-stained ependymal layers with
virtually absent PV-immunoreactivity (g, g1), whereas adhered LV walls display Foxj1-eGFP1/PV1 cell islands (h). Thin layer reconstruction
of few z-planes (approximately 4 mm thick) demonstrates that PV and eGFP are co-expressed in the same cells (h1). Confocal z-stack maxi-
mum overprojection of GFAP-immunostaining shows GFAP-immunopositive processes infiltrated in the adhesion site, with no co-
expression of GFAP and Foxj1-eGFP or PV in the LV-wall adhesions cells (i). The scattered eGFP-positive cells medial to the LV walls (g, h,
asterisks) might represent ectopic eGFP-expression. d5dorsal; l5 lateral; LV5 lateral ventricle; m5medial; v5 ventral
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FIGURE 3 PV-immunopositive ependymal cells in the LV-wall adhesions acquire reactive phenotype, similarly to injury-reactive ependymal
cells. Confocal laser z-stack overprojections of 4-month-old C57BL/6 mice display PV- and S100B-co-stained ependymal cells in the region
of the LV-wall adhesions (a–d, adhered LV walls marked by dashed lines). Thin layer reconstruction of few z-planes is shown in (d1). The
insets in (b–d) depict an example from another animal in a corresponding region of LV-wall adhesion. Confocal laser z-stack overprojection
of 8-month-old Foxj1-eGFP mice depicts eGFP1/PV1 cells in the LV-wall adhesion (e–h, adhered LV walls marked by dashed lines), magni-
fied thin layer reconstruction image is shown in (h1). Some of the PV-expressing ependymal cells possess elongated cellular processes that
extend into the adhesion (c, g, arrows). This cell morphology suggests a reactive phenotype, and resembles that observed in reactive post-
injury ependymal cells (i–k). Unilateral in vivo stab-wound (marked by a dashed line) over the cortex and LV wall was performed in Foxj1-
eGFP mice (i). One week following lesion, GFAP-immunostaining depicts reactive astrocytes around the stab-wound in the parenchyma,
while GFP-staining reveals a lesioned, interrupted ependymal layer (i). Confocal z-stack overprojections of the ependymal layer adjacent to
the stab-wound injury display several reactive eGFP1 cells with long basal processes extending into the parenchyma, approximately per-
pendicularly to the ependymal layer (j, k, arrows). Some of these Foxj1-eGFP1 ependymal cell processes co-express PV, as shown in thin
layer (of approximately 3 mm thickness) reconstruction image in (j1). Cell morphological features seen in (j) and (k) are similar to those of
PV-immunopositive ependymal cells found in the LV-wall adhesions (a–h). inj.5 stab-wound injury; LV5 lateral ventricle
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offset, etc.) were set to maximize signal-to-noise ratio and to avoid
over- or underexposure throughout the entire z-volume of the samples,
following well-established guidelines (Waters, 2009). Double- or triple-
stained sections were imaged at 8-bit color depth, 1,024 3 1,024 pixel
format and 200 Hz scan speed as z-stacks using sequential scanning
mode, the emission bandwidths being 418–487 nm (laser intensity
30%, active gain 498 V, offset 21) for DAPI, 503–543 nm (AOTF
intensity 15%, active gain 844 V, offset 26) for Alexa Fluor 488-
conjugated fluorescent secondary antibodies, 572–630 nm (AOTF
intensity 15%, active gain 497 V, offset 22) for Cy3-conjugated fluo-
rescent secondary antibodies, 650–729 nm (AOTF intensity 15%,
active gain 745 V, offset 23) for Alexa Fluor 647-conjugated second-
ary antibodies.
2.8 | Fluorescence intensity quantification
Maximum intensity projections of confocal z-stacks acquired from cor-
onal brain sections in the regions encompassing the rostral LVs were
used to measure the fluorescence intensity of the PV- and GFAP-
immunostaining in the ventricular and periventricular area of the LV
walls. Briefly, SRS series of coronal sections were prepared as
described above from C57BL/6 adult mice (n58, 4- to 15-month-old)
and the regions encompassing the LVs were imaged by confocal z-
stack acquisition maintaining the same settings of gain, AOTF intensity
and offset throughout the analysis of all the animals. Confocal z-stack
image series were superposed in maximum intensity projections by
ImageJ. The overprojection images were merged together applying the
“Pairwise stitching” plugin in ImageJ to allow the visualization of the
entire dorsoventral extent of the LVs. The areas lying outside the peri-
ventricular region were manually cleared to exclude intensity measure-
ment of PV- and GFAP immunostained regions outside the regions of
interest (ROIs). Briefly, the workflow of the fluorescence intensity mea-
surement was performed as follows. The merged, cleared 8-bit images
of PV-, respectively GFAP-immunostaining of both LVs from six coro-
nal sections of all animals were added into one image sequence, thus
creating 12 images per animal. The periventricular PV- and GFAP-
immunofluorescence intensity was analyzed separately. The particle
analysis by ImageJ requires 8-bit greyscale images with 256 intensity
graduations which can be assigned to a pixel (pixel intensity 0 corre-
sponding to no signal, while 255 to maximal signal). Therefore, a
threshold range was set to tell the objects of interest apart from the
background by the “Adjust threshold” command in ImageJ. After test-
ing several thresholding settings, we defined the optimal threshold to
be 70–255 for the entire image sequence, thus excluding the analysis
of all the pixels whose intensity value was below 70. We then sub-
jected the image sequence to the “Analyze particles” plugin, by apply-
ing no particle size filter or circularity filter. Area, mean, minimal and
maximal gray value, standard deviation, area fraction, and integrated
density were measured and summarized for each image, and exported
as Excel tables. IntDen is the product of the area and the mean gray
value, reflecting the total area and fluorescence intensity of PV-,
respectively GFAP-immunofluorescence of each image of the LVs. The
mean IntDen corresponds to the average IntDen of the periventricular
regions of six coronal sections after subtraction of the IntDen values of
the negative controls (28.17612.4 for PV and 33.8764.85 for GFAP)
from each value. Negative control sections were incubated with the
secondary antibodies only, and the regions of the LV-wall adhesions
were processed for confocal imaging as described above, followed by
the fluorescence intensity measurement workflow described here.
In another set of experiments, Iba1-immunostained coronal sec-
tions of WT (n56) and PV-KO (n56) mice of different ages ranging
from 6- to 15-month-old were imaged by a Leica DM 6000B fluores-
cent microscope. In the regions encompassing the LV wall adhesions, at
least four 40-mm-thick-sections—spaced 160 mm from each other—per
mouse were imaged, maintaining the same settings of image acquisition
for all the animals. Several ROIs with an area of 268.57 mm 3
307.62 mm were defined in the images; in the regions of the LV-wall
adhesions and in the striatum adjacent to the LV walls in the same sec-
tion serving as control Iba1-staining. All the images were added into a
single image sequence, which was subjected to the fluorescence inten-
sity measurement workflow described above. We defined the optimal
threshold to be 50–255 for the entire image sequence, and subjected it
to the “Analyze particles” plugin applying a particle size filter15 mm2.
Area, mean, minimal and maximal gray value, standard deviation, area
fraction, and IntDen were measured and summarized for each image in
the image sequence, and exported as Excel tables. The mean IntDen val-
ues of the Iba1-immunofluorescence intensity of the LV-wall adhesions,
respectively the striatum represent the average of the analyzed sec-
tions. The mean IntDen values in the LV-wall adhesions were compared
with the values of the striatum as control.
2.9 | Statistics
To compare the data sets, statistical strength was analyzed by Graph-
Pad Prism 7 (RRID:SCR_002798) using ordinary one-way ANOVA with
Sidak’s multiple comparisons test upon verification of the Gaussian
distribution of the data, and Kruskal-Wallis test with Dunn’s multiple
comparisons test when Gaussian distribution of the data failed. Curves
were analyzed by linear regression analysis in GraphPad Prism 7 where
goodness of fit (R square) and the significance of the slope’s deviation
from zero were calculated.
3 | RESULTS
3.1 | PV-expressing ependymal cells of reactive
phenotype can be found in LV-wall adhesions of
nonaged WT mice
In young adult (4-month-old) C57BL/6 mice (n55), we found the lat-
eral and medial walls of the rostral portion of the LV to adhere to each
other, resulting in unilateral or bilateral ventricle stenosis. We observed
that the nonadhering LV walls displayed an uninterrupted, healthy
ependymal layer visualized by the ependymal-cell marker S100B with
virtually absent PV-expression (Figure 2a,c). However, in the regions of
LV-wall adhesion, the ventricle walls partially lacked an intact ependy-
mal layer (Figure 2b). Instead, patches of S100B-stained ependymal-
cell islands could be observed in the adhesions (Figure 2b, arrows),
which also displayed PV-immunoreactivity in addition to S100B-
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expression (Figure 2d). We also examined the single z-planes of the
confocal z-stacks for co-expression, and we found S100B1/PV1 cells
in the adhered LV walls (Figure 2d1, thin layer reconstruction). Large
portions of the adhered LV walls were devoid of an S100B1 ependy-
mal layer, which is in line with previous observations that described the
loss of ependymal cells in the LV-wall fusions in aging mice (Shook
et al., 2012). We also examined if ependymal cells in LV-wall adhesions
co-expressed the astrocyte marker GFAP, similarly to reactive ependy-
mal cells following mechanical injury (Szabolcsi & Celio, 2015) and
stroke (Young et al., 2013). We found GFAP-immunopositive processes
to infiltrate the adhesion site and to intermingle with the PV1 cells
(Figure 2f); however, upon examination of single confocal z-planes
throughout the adhesion site and thin layer reconstructions, we did not
detect co-expression of GFAP and PV in the same cells (Figure 2f1).
The nonadhering LV walls also displayed numerous strongly stained
GFAP-positive processes in the ependymal layer (Figure 2e). The dense
periventricular GFAP-immunostained astrocytic processes reflect ven-
tricular astrogliosis (hereafter: ventricular gliosis) which is associated
with ventriculomegaly in the human and murine brain (Shook et al.,
2013). By visual observation, ventricular gliosis represented by GFAP-
immunostaining did not appear to be more pronounced in the LV-wall
adhesion site than in the nonadhered LVs (Figure 2e,f).
Given that S100B labels astrocytes in addition to ependymal cells
(Cocchia, 1981), we used an additional approach to ascertain that PV-
expressing cells in the LV-wall adhesions were indeed of ependymal
origin. In a second set of experiment, we examined the LV walls of 8-
month-old Foxj1-eGFP mice (n55). The forkhead transcription factor
FoxJ1 regulates ciliogenesis in mice and it is required for the differen-
tiation of radial glial cells into ependymal cells. Foxj1-driven eGFP-
expression in the brain is restricted to ependymal cells (see also Figure
3i) and to a small subset of Foxj1-positive astrocytes derived from the
ventricular zone (Jacquet et al., 2009; Ostrowski et al., 2003). PV- and
GFP-immunostained coronal sections displayed strongly GFP-stained
ependymal layers in the nonadhering LV walls, with virtually absent
PV-immunoreactivity (Figure 2g,g1). In the LV-wall adhesions, islands
of Foxj1-eGFP1/PV1 cells were present (Figure 2h). PV and
eGFP were co-expressed in the same cells, as shown by thin layer
reconstruction of the confocal z-stacks (Figure 2h1). Although GFAP-
immunopositive processes infiltrated the adhesion site, Foxj1-eGFP
expressing cells in the LV-wall adhesions did not co-express GFAP
(Figure 3i). Therefore, we assume that Foxj1-eGFP1/PV1 cells in the
LV-wall adhesions were of ependymal origin. In Foxj1-eGFP mice, in
addition to the extensive eGFP-expression in the ependymal layer of
the ventricular zone, we also observed scattered eGFP-expressing cells
medially from the LV walls (Figure 2g,h, asterisks), which did not co-
express PV or GFAP. These scattered Foxj1-eGFP positive cells are
present in a region corresponding to the lateral septal nucleus and
might represent an ectopic eGFP-expression in this mouse line given
that the cells do not co-express astrocyte markers (GFAP or S100B,
data not shown). The entire image sequences of the confocal z-stacks
from Figures 2–3, and 7, respectively of the negative controls (not
shown) have been deposited as an open access data set on Zenodo
(http://doi.org/10.5281/zenodo.437943).
3.2 | PV-expressing ependymal cells in LV-wall
adhesions acquire a reactive phenotype
When we examined the morphology of PV-stained ependymal cells of
the LV-wall adhesions (Figure 3a–d), we observed elongated, bipolar
cell shape with long, thin cellular processes (Figure 3c, arrows), which
co-expressed the ependymal-cell marker S100B (Figure 3d). We
observed similar cell morphology when we analyzed the LV-wall adhe-
sions of Foxj1-eGFP mice (Figure 3e–h). Many of the Foxj1-eGFP
expressing cells in the LV-wall adhesions co-expressed PV (Figure 3h1),
and some of them displayed elongated cell shape and long cellular
processes (Figure 3g, arrows). Normally, ependymal cells are character-
ized by a cuboidal to columnar shape, apical-basal polarity, and planar
cell polarity typical of epithelial-like cells (Del Bigio, 2010; Mirzadeh,
Han, Soriano-Navarro, Garcia-Verdugo, & Alvarez-Buylla, 2010). The
morphological features we observed in PV-expressing ependymal cells
in LV-wall adhesions resemble that of a reactive phenotype seen fol-
lowing lesion of the ependymal layer (Szabolcsi & Celio, 2015) or stroke
(Young et al., 2013). In an in vivo model of penetrating brain injury, in
which we inflicted a stab-wound lesion onto the dorsal LV wall in a
more caudal portion of the LVs in adult Foxj1-eGFP mice (Figure 3i),
we found injury-reactive Foxj1-eGFP1 ependymal cells adjacent to the
lesion to extend long processes characteristic of reactive phenotype
(Figure 3j,k). Numerous injury-reactive ependymal cells also co-
expressed PV (Figure 3j,j1), as we described earlier (Szabolcsi & Celio,
2015). When studying the direction in which ependymal-cell processes
found in the LV-wall adhesions extended, we observed that they
stretched out parallel to the former ventricle surface, along the dorso-
ventral axis of the adhesion (Figure 3c,g, arrows), whereas post-injury
ependymal-cell processes extended basally (Figure 3j,k). One could as
well assume that ependymal cells in the adhering LV walls alter their
position in the ependymal layer or even lose their cell polarity com-
pletely, in addition to acquiring a reactive phenotype. This could be
explained if we presume a disintegration of the previously normal
ependymal layers caused by adhesions of the opposite LV walls, which
might ultimately lead to the transposal of the basal processes along the
dorsoventral axis.
3.3 | The volume of LV-wall adhesion shows
reciprocal correlation to the volume of the rostral LV
Next, we aimed to quantify the grade of ventricle stenosis in WT,
respectively in PV-KO mice. As LV-wall adhesions affect the rostral
portion of the LV, we analyzed the region approximately between
Bregma levels 11.5 and 0 mm, corresponding to the rostral part of the
LV in the murine brain. We used stereological volume estimation to
measure the volumes of the LV-wall adhesions and the LVs in adult (6-
to 15-month-old) PV-KO (n518, both sexes) and WT mice (n513,
both sexes). We found that the volume of the LV-wall adhesion
showed a strong reciprocal correlation to the LV volume both in WT
(Figure 4a) and PV-KO mice (Figure 4b). Based on this finding, we
deduced that the volume of the LV-wall adhesion (hereafter: adhesion
volume) reflects well on the adhesion extent, therefore on the grade of
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ventricle stenosis. We also examined if there was any difference
regarding the values of measured parameters between female and
male PV-KO and WT mice. We found no differences between PV-KO
and WT males or between PV-KO and WT females regarding the ros-
tral LV volume (Figure 4c) or the adhesion volume (Figure 4d). There-
fore, we used mice of both sexes throughout the study.
3.4 | PV-immunofluorescence intensity in the LV walls
correlates to the adhesion volume but not to the LV
volume in <10-month-old mice, whereas
periventricular GFAP-immunofluorescence intensity
shows no correlation
Owing to the dense organization of the cell nuclei in the ependymal
layer and the characteristics of GFAP-staining that labels the cellular
processes and not the cell bodies, we faced difficulty to count PV-
and GFAP-immunopositive cells around the LV walls. Therefore, we
decided to quantify the intensity of immunofluorescence on confocal
laser micrograph z-stack overprojections after manually subtracting the
areas outside the periventricular region. We quantified the PV- and
GFAP-immunofluorescence intensity in the region of the rostral LV
walls and compared the values to the adhesion volume—reflecting
adhesion extent—and to the rostral LV volume in C57BL/6 mice
(n58). We used the IntDen (ImageJ) as the parameter that reflects the
fluorescence intensity at the best, as it is the product of the area and
the mean gray value. Cleared confocal z-stack overprojection micro-
graphs encompassing the rostral portions of the LVs were processed
for particle analysis following threshold adjustment by ImageJ, and the
IntDen values were presented as means per ventricle upon averaging
and subtraction of the IntDen values of the negative controls. We plot-
ted the fluorescence intensity values relative to adhesion volume and
to LV volume, and found that in mice younger than 10-month-old,
FIGURE 4 LV-wall adhesion volume is reciprocally correlated to the rostral LV volume in both WT and PV-KO mice. The volume of the
LV-wall adhesions and the LVs in the rostral portion of the brain (approximately Bregma levels 11.5 to 0 mm) was quantified with stereo-
logical methods in adult (6- to 15-month-old) PV-KO (n518) and WT mice (n513). LV-wall adhesion volume is in reciprocal correlation
with the LV volume in both WT (R250.7739, a) and PV-KO mice (R250.6393, b). LV-wall adhesion volume therefore reflects well on the
grade of ventricle stenosis. We compared the LV volume and adhesion volume between male and female mice. The LV volume values do
not differ significantly between PV-KO and WT males, between PV-KO and WT females, or between males and females in either PV-KO or
WT mice (c). Similarly, no significant differences were found regarding adhesion volume (d). Statistical analyses between the groups were
performed by one-way ANOVA. Error bars show the standard error of the mean (SEM)
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PV-immunofluorescence was positively correlated to the volume of
the LV-wall adhesion. The correlation between IntDen of the
PV-immunofluorescence and adhesion volume was found to be signifi-
cantly linear (R250.4516, p5 .0474, n55) (Figure 5a). In the same
group of animals, no correlation between periventricular PV-
immunofluorescence and LV volume was found (Figure 5c), further-
more, GFAP-immunofluorescence intensity reflected by IntDen mean
correlated neither to the adhesion volume (Figure 5b) nor to the LV
volume (Figure 5d). In older mice (>10-month-old, n53), we found no
correlation between the above-mentioned parameters (data not
shown). These findings suggest that the presence of PV1 ependymal
cells in the adhering LV walls is linked to the stenosis grade at the early
stages of the course of LV-wall fusion. In aged mice, in which perma-
nent LV-wall fusions are already formed, no such correlation applies.
On the other hand, ventricular gliosis reflected by periventricular
GFAP-staining seems to be unrelated to the extent of LV-wall adhesion
and ventricle stenosis grade in all the examined age groups. This is in
line with the observation that ventricular gliosis is associated with ven-
triculomegaly, whereas no such link to ventricle stenosis has been
described (Shook et al., 2013). Based on these results, we presume that
the early presence of PV1 ependymal cells and not ventricular gliosis
is associated with the formation of LV-wall fusions, which then leads
to ventricle stenosis and SVZ-decline throughout aging.
3.5 | S100B1/PV1 ependymal cells diminish in LV-
wall adhesions in aging mice, whereas periventricular
gliosis changes spatial distribution
Based on these results, we raised the question whether PV-
immunoreactivity in LV-wall adhesion ependymal cells declines in older
mice. Therefore, we analyzed the LVs of 4-month-old (n53), 8-month-
old (n55), and 15-month-old (n53) WT mice. Co-immunostaining for
S100B, GFAP and PV showed S100B1/PV1 ependymal cell clusters
in the LV-wall adhesions of 4-month-old (Figure 6a, arrows) and 8-
FIGURE 5 Periventricular PV-immunofluorescence is positively correlated to LV-wall adhesion volume and not to LV volume in mice
younger than 10-month-old, whereas no correlation applies for periventricular GFAP-immunofluorescence. Periventricular PV- and GFAP-
immunofluorescence intensity was quantified in confocal z-stack overprojection images of coronal sections of C57BL/6 mice (aged between
6 and 15 months, n58) upon excluding regions outside the periventricular area. Following threshold adjustment and particle analysis by
ImageJ, the integrated density (IntDen, product of area and mean gray value) of PV- and GFAP-immunofluorescence images was calculated
and averaged following subtraction of the IntDen values of the negative controls. The mean IntDen was plotted relative to the adhesion
volume and to the LV volume. In nonaged mice (<10-month-old, n55), PV-immunofluorescence showed positive linear correlation to the
adhesion volume (R250.4516, p5 .0474, one outlier removed) (a). No significant correlation applied between PV-immunofluorescence and
LV volume (b), or between GFAP-immunofluorescence and adhesion volume (c), respectively LV volume (d). In older mice (>10 month-old,
n53), none of the above-mentioned parameters were found to be correlated
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month-old (Figure 6b, arrows) mice, whereas such ependymal-cell pop-
ulations were almost entirely lacking in 15-month-old mice (Figure 6c).
This is in line with the observations that PV-staining intensity in the
LV-wall adhesions correlates with adhesion volume—reflecting adhe-
sion extent—in mice aged less than 10-month-old, but not in mice over
10 month of age, respectively with previous works that reported the
disappearance of S100B1 ependymal cells from the LV-wall adhesions
in 1-year-old mice (Shook et al., 2012).
GFAP-positive processes reflecting astrocytes could be found
along the entire length of the LV-wall adhesions in 4-month-old
mice (Figure 6a, arrowheads), whereas in 8- and 15-month-old mice
GFAP1 astrocyte processes were found to be concentrated mostly
FIGURE 6 With aging, S100B1/PV1 ependymal cells decline in the LV-wall adhesions, whereas the distribution of ventricular gliosis
undergoes spatial transposition. Confocal laser z-stack overprojection images of coronal sections from 4-month-old (a), 8-month-old (b),
and 15-month-old (c) mice encompassing the regions of LV-wall adhesions (delineated by dashed lines) were immunostained for PV, S100B,
and GFAP. Patches of S100B1/PV1 ependymal cells can be observed along the adhered ventricle walls in 4-month-old (a, arrows), respec-
tively in 8-month-old mice (b, arrows). In 15-month-old mice, S100B1/PV1 cells are almost entirely lacking from the LV-wall adhesion
zone (c). GFAP-immunostaining can be observed along the entire length of the adhering LV walls in 4-month-old mice (a, arrowheads). In 8-
month-old mice, GFAP-stained processes are confined to the close vicinity of the LV (b, arrowheads), whereas it is largely lacking in the LV-
wall adhesions. Similar is the situation in 15-month-old mice (c, arrowheads)
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around the ventricle-contacting areas of the LV-wall adhesions (Fig-
ure 6b,c, arrowheads). These findings suggest that LV-wall adhesions
display some degree of gliosis along the adhering LV walls in early
stages of ventricle stenosis, whereas later on periventricular gliosis is
transposed to the surroundings of the ependymal layer that contacts
the ventricle, and diminishes in the fused LV walls which lost ven-
tricular contact.
3.6 | LV-wall adhesions of PV-KO-eGFP mice display
crucial morphological alterations throughout aging
Next, we raised the question if PV-expressing ependymal cells in LV-
wall adhesions contribute significantly to the progression of LV-wall
fusions seen in aged mice. We found by visual observation that older
PV-KO mice exhibited a reduced grade of ventricle stenosis than that
of WT mice (Figure 7a,b). We also examined the LVs of PV-Cre/eGFP
FIGURE 7 LV-wall adhesions of PV-KO-eGFP mice display crucial morphological alterations throughout aging. Low magnification image of
a DAPI-counterstained coronal section at the level of the rostral portion of the LV reveals severe unilateral ventricle stenosis in a 13-
month-old WT C57BL/6 mouse (a), whereas the LVs at approximately the same level display no adhesions in an 11-month-old PV-KO
mouse (b). Confocal laser z-stack overprojection image of coronal sections encompassing the LV-wall adhesion region displays adhering LV
walls with eGFP1 ependymal cells in the adhered ependymal layers in 6-month-old (c) and 14-month-old PV-Cre/eGFP (e) mice. Periven-
tricular GFAP-immunopositive astrocyte processes can be found along the adhering ventricle walls (c, e), whereas eGFP1 cells are numer-
ous in the LV-adhesion of 6-month-old (c, arrowheads) but virtually absent in the 14-month-old (e) PV-Cre/eGFP mouse. Confocal laser z-
stack overprojection image in a 6-month-old PV-KO-eGFP mouse also demonstrates adhesions between the LV walls, with intensive GFAP
(d, arrows) and S100B-immunostaining (d1) along the adhering ependymal layers. Several eGFP1 cells are present in the ependymal layers
(d, arrowheads). Thin layer reconstruction of approx. 5 mm thickness depicts the S100B-positive ependymal layer to co-express GFAP (d2).
Eleven-month-old PV-KO-eGFP mice display nonadhering LV walls with numerous eGFP1 cells in the ependymal layers (f, arrowheads).
S100B-staining appears mostly intact in the 11-month-old PV-KO-eGFP mouse (f1), whereas some GFAP-stained patches can be found
along the LV-wall thickenings (f, arrows). Thin layer z-reconstruction of S100B- and GFAP-immunostaining is shown in (f2)
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(n56) and PV-KO-eGFP (n55) mice of different ages. When we com-
pared nonaged (6-month-old) PV-KO-eGFP and PV-Cre/eGFP mice,
we often found adhering medial and lateral LV walls in PV-KO-eGFP
mice (Figure 7d); similarly to PV-Cre/eGFP ones of the same age (Fig-
ure 7c). In 6-month-old PV-KO-eGFP, numerous eGFP1 cells were
present in the adhering ependymal layers (Figure 7d, arrowheads);
moreover, the LV walls displayed extensive GFAP-immunostaining (Fig-
ure 7d, arrows). The LV walls also retained an intact S100B-staining,
despite the presence of apparent adhesions (Figure 7d1). Thin z-plane
reconstruction showed the S100B-positive ependymal layer to express
GFAP (Figure 7d2). Six-month-old PV-Cre/eGFP mice formed LV-wall
adhesions with evident ventricle stenosis, GFAP-stained periventricular
astrocyte processes, and numerous eGFP1 cells in the LV-wall adhe-
sions (Figure 7c, arrowheads). In aging (14-month-old) PV-Cre/eGFP
mice, we found a severe grade of ventricle stenosis, GFAP-stained
astrocytes around the LV walls, but virtually absent eGFP1 cells in the
LV-wall adhesions (Figure 7e). These findings are in line with our obser-
vations described earlier (see Figure 6c). When we examined aging (11-
month-old) PV-KO-eGFP mice, we found nonadhered LV walls with
several “thickenings” in the ependymal layers (Figure 7f), which dis-
played patchy GFAP-immunostaining (Figure 7f, arrows, f2). Similarly
to 6-month-old PV-KO-eGFP mice, numerous eGFP1 cells were found
in the nonadhered LV walls (Figure 7f, arrowheads). Additionally, we
found the LV walls to possess a virtually intact S100B-staining of the
ependymal layers (Figure 7f1). These morphological differences
between PV-Cre/eGFP and PV-KO-eGFP mice are quite striking: in PV-
KO-eGFP, adhering LV walls displayed uniform GFAP-immunoreactivity,
suggesting that the affected portions of the ependymal layer upregulated
the astrocyte marker GFAP, unlike their WT counterparts. On the other
hand, PV-KO-eGFP ependymal layers retained intact S100B-staining
even in adhering LV walls, which could be explained if we assume that
PV-KO adhesions less frequently formed persistent LV-wall fusions than
those of WT mice. In line with this, PV-KO-eGFP ependymal layers dis-
played numerous eGFP1 cells even in older mice, suggesting that the
Pvalb promoter remained active in these ependymal cells, but a perma-
nent fusion of the LV walls did not yet occur. In other words, the progres-
sion of LV-wall adhesion into irreversible LV-wall fusions seems to be
lacking or considerably delayed in PV-KO-eGFP mice, potentially due to
the absence of a functional PV protein.
3.7 | Mid-aged PV-KO mice (10–15-month-old) has
significantly reduced ventricle stenosis grade when
compared to their WT counterparts
Next, we quantified and compared the adhesion volume and the LV vol-
ume in adult (6–15-month-old) WT C57BL/6 (n513) and PV-KO
(n518) mice. We found that younger mice (6–9 month old) displayed
no significant differences in adhesion volume [8,818,400
mm361,567,792 SEM in PV-KO (n510) vs. 8,150,400
mm361,165,999 SEM in WT (n55), see Figure 8a] or in adhesion vol-
ume/LV volume percentage (1.164%60.2546 SEM in PV-KO vs.
1.163%60.2963 SEM in WT, see Figure 8b). However, we found a
43.3% reduction in adhesion volume [6,471,000 mm361,169,527 SEM
in PV-KO (n58) vs. 11,406,00061,264,634 SEM in WT, (n58),
p5 .0282, see Figure 8a]; and a 49.6% reduction in adhesion volume/
LV volume percentage (1.048%60.2583 SEM in PV-KO vs. 2.079%6
0.3809 in WT, p5 .0221, see Figure 8b) in older (10–15-month old)
PV-KO mice when compared to their WT counterparts. When we com-
pared the age-grouped values in the same genotype, we found no sig-
nificant differences between younger and mid-aged WT mice, or
between younger and mid-aged PV-KO mice. A tendency of increase in
adhesion volume and adhesion volume/LV volume percentage in mid-
FIGURE 8 Mid-aged PV-KO mice exhibit lower grade of ventricle stenosis than their WT counterparts. The adhesion volume and rostral
LV volume were measured by stereological volume estimation in PV-KO (n518) and WT (n513) mice and are represented as age-grouped
mean values. We analyzed the region corresponding to the rostral part of the LV (approximately between Bregma levels 11.5 and 0 mm).
No significant differences could be seen between younger (<10-month-old) PV-KO and WT mice (a, b); however, 10–15-month-old PV-KO
mice displayed significantly lower adhesion volume (a), respectively adhesion volume/LV volume percentage (b) than did their WT counter-
parts. Statistical analyses were performed by one-way ANOVA and Kruskal-Wallis test. Error bars represent the SEM. *p< .05
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aged WT, respectively a tendency of decrease in mid-aged PV-KO could
be observed, however, the differences were not significant. The finding
that mid-aged PV-KO exhibit reduced grade of ventricle stenosis when
compared to WT is in line with our other observations in this study, and
suggests an involvement of PV-expressing ependymal cells in the for-
mation of permanent fusions between the medial and lateral LV walls,
thereby, in the progression of aging-associated ventricle stenosis.
3.8 | Microglial activation was observed in both
PV-KO and WT LV-wall adhesions, with a delay
in PV-KO mice
We postulated that at some point during the progression of fusion
between medial and lateral LV walls microglial activation was impli-
cated, since microglial cells were previously shown to exhibit robust
activation, phagocytosis of ependymal debris and migration upon
FIGURE 9 Microglia is activated in the LV-wall adhesion in both WT and PV-KO mice, however, at different extent between age groups.
Fluorescent micrographs displaying Iba1-immunostaining on coronal sections—at the level of LV-wall adhesions—of age-grouped PV-KO and
WT C57BL/6 mice show visibly more enhanced Iba1-immunofluorescence in the adhesion zone (marked by dashed lines) than in the control
region of the striatum in each of the presented age groups and genotypes (a). Iba1-immunofluorescence intensity (integrated density—
IntDen) was quantified on a series of ROIs in the control, respectively adhesion regions following threshold adjustment and particle analysis
by ImageJ. In the graph, IntDen is displayed as mean IntDen values following averaging (b). Significant increase of Iba1-immunofluorescence
is seen in the LV-adhesions of each group when compared to the control region (b). The table shows the IntDen adh/ctr percentage values
in the different age groups. Statistical analysis was performed by Kruskal-Wallis test. Error bars show SEM. adh5 adhesion; ctr5 control.
*p< .05, **p< .005, ****p< .0001
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periventricular damage (Carbonell, Murase, Horwitz, & Mandell, 2005).
The increased expression level of the microglia marker Iba1 was shown
to be associated with microglial activation (Ito, Tanaka, Suzuki,
Dembo, & Fukuuchi, 2001), therefore, we quantified Iba1-
immunoreactivity in adult PV-KO and WT mice in the LV-wall
adhesions and in the striatum as control in the different age groups
(Figure 9a). Iba1-immunofluorescence—measured as integrated density
(IntDen) by ImageJ upon threshold adjustment in defined ROIs (268.57
mm 3 307.62 mm)—of the LV-wall adhesions was compared to the con-
trol Iba1-staining in the striatum on the same sections. We found a sig-
nificant increase of Iba1-immunoreactivity in the LV-adhesions in both
younger (6–9 month-old) and older (10–15 month-old) WT and PV-KO
mice (Figure 9b). The degree of increase was however somewhat dif-
ferent between the age groups: 6–9 month-old WT mice displayed a
188.48% increase (p< .0001) in IntDen in the LV-wall adhesion when
compared to the Iba1-immunofluorescence of the striatum, whereas
10–15 month-old WT displayed a 150.99% increase (p5 .0033). In PV-
KO mice, younger animals (6–9 month-old) exhibited a 140.65%
increase (p5 .0426), and mid-aged mice (10–15 month-old) a 184.23%
increase (p< .0001) (Figure 9b). These findings reflect a slight, ca. 20%
decrease in microglial activity in LV-wall adhesions of mid-aged mice
compared to younger ones in WT, whereas a ca. 130% increase in mid-
aged PV-KO mice compared to younger PV-KO mice, suggesting a
time-shift in microglial activity in the region of LV-wall adhesions when
PV is lacking from ependymal cells. This could be explained by a delay
in the formation of LV-wall fusions in PV-KO, resulting in a later on-set
of microglial recruitment in the affected areas.
4 | DISCUSSION
We found PV-immunopositive ependymal cells in the adhered layers of
the rostral LV walls of nonaged WT mice, which co-expressed the
ependymal cell marker S100B and displayed a reactive phenotype simi-
lar to injury-reactive ependymal cells described in our previous study
(Szabolcsi & Celio, 2015). The aim of our study was to investigate the
relevance of PV-positive ependymal cells in LV-wall adhesions. We
found that periventricular PV-immunoreactivity correlated to the grade
of LV stenosis in mice younger than 10 month of age. In line with this
observation, we found significantly lower grade of ventricle stenosis in
older PV-KO mice, suggesting that PV-expressing ependymal cells con-
tribute to the early stages of the formation of LV-wall fusions, and con-
sequently to the progression of LV stenosis. We observed that
throughout aging, as adhesion/fusion of the LV walls progresses, PV-
expressing ependymal cells diminished from the LV-wall fusions. We
quantified the grade of ventricle stenosis of PV-KO and C57BL/6 WT
mice, and found significantly lower adhesion extent and stenosis grade
in mid-aged (>10-month-old) PV-KO mice when compared to their
WT counterparts, whereas no difference was found between younger
(<10-month-old) PV-KO and WT mice. Thus, our findings highlight an
important involvement of PV-expressing ependymal cells found in
adhering LV walls in the aging-associated progression of ventricle
stenosis.
During the course of ventricle stenosis, mice develop fusions of
the medial and lateral LV walls with a resulting deterioration of the ini-
tially intact ependymal layer and most importantly, a decline of the
functional proliferative zone in the affected SVZ in the regions of the
LV-wall fusions (Luo et al., 2006; Shook et al., 2012). Ependymal cells
lining brain ventricles display only limited regenerative capacities since
they are fully differentiated (Spassky et al., 2005), and they have been
shown to irreversibly disappear from the ventricle wall adhesions
throughout aging (Shook et al., 2012). Considering this together with
the loss of neurogenic SVZ in the adhesions, LV-wall adhesions signifi-
cantly contribute to the pathophysiology of aging. The mechanisms
and precise cellular interplay which ultimately lead to the adhesion of
the LV walls remain unknown, but we demonstrate here that adhering,
PV-expressing ependymal cells are implicated in this process, whereas
periventricular gliosis does not seem to play a crucial role.
Several factors could be involved in the progression of LV-wall
fusions. Some ependymal-cell responses to deleterious effects have
been investigated and stressed the importance of the maintenance of
an intact ependymal lining. In the aging SVZ, dying ependymal cells are
replaced by dividing astrocytes, probably to maintain an intact CSF-
SVZ barrier (Luo et al., 2008). On the other hand, excessive loss of
ependymal cells results in extensive gliosis at the ventricle surface with
following ventriculomegaly (Shook et al., 2013). Ventricle enlargement
in the human brain has been attributed to neurological/psychiatric ill-
nesses (Palha et al., 2012); however, Shook et al. showed that ependy-
mal loss and consequent periventricular gliosis alone could lead to
ventriculomegaly, independent of neurodegeneration. Thus, the integ-
rity of the ventricle barrier formed by the ependymal monolayer is cru-
cial to maintain the normal volume of the brain ventricles.
Nevertheless, the rate of production and absorption of CSF might also
alter the brain ventricle volume, potentially leading to ventriculomegaly
or ventricle stenosis. Alterations in the microarchitecture of the SVZ
might also contribute to events that compromise the barrier integrity.
Ependymal-cell responses to these factors might be very variable.
Mature ependymal cells in the brain do not reenter the cell cycle
under normal conditions; however, they have been shown to generate
new neurons and glial cells upon disruption of Notch signaling (Carlen
et al., 2009). Nevertheless, they fail the “stemness” criteria due to
their incapability of self-renewal. Thus, their primary role in the brain
seems to lay in providing an important barrier between CSF and brain
parenchyma. We have recently described the injury-induced PV-
upregulation in ependymal cells, which displayed reactive phenotype,
enhanced cell motility and wound-closure capacity upon PV-
expression (Szabolcsi & Celio, 2015). We showed that such PV-
expression in ependymal cells was NF-ƘB signaling dependent and
could be modulated by altering the level of oxidative stress, thus
implicating injury-induced inflammation in this process. We also found
previously that injury-reactive ependymal cells acquired a reactive
phenotype, which resembles that of ependymal cells in the LV-wall
adhesions described in our present study. This suggests that ependy-
mal cells that undergo disintegration due to either mechanical lesion or
adhesions of the LV walls react in similar ways: with PV-upregulation
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and phenotype shift from cuboidal, epithelial-like cells to bipolar cell
morphology with elongated processes.
This type of reaction of challenged ependymal cells might be
caused by an altered extracellular milieu and cellular interplay that
accompanies tissue remodeling, such as cytokines released by activated
microglial cells. In our present study, we indeed found activated micro-
glial cells in the zone of LV-wall adhesions and fusions, supporting a
possible role for microglia-mediated factors in the observed alteration
of ependymal cells. However, microglial activation could also be a con-
sequence rather than a cause of reactive ependymal phenotype. Reac-
tive ependymal cells might also exert antigen-presenting functions and
thereby facilitate microglial recruitment.
Nevertheless, the molecular triggers underlying ventricle stenosis,
respectively those inducing a reactive phenotype in ependymal cells
are as yet unknown. The disruption of the liquor-brain barrier upon dis-
integration of the ependymal monolayer by mechanical lesion or fusion
of the opposite LV walls might generate increased cellular stress that
switch on defensive cell mechanisms in this cell type. Additionally, los-
ing contact to neighboring ependymal cells might lead to a loss of
apical-basal polarity and changes in cell shape, that is, to a loss of
epithelial-like phenotype. Given that the ependymal layer, unlike other
epithelial linings, is nonregenerative; the capacity of ependymal cells
for local remodeling is very limited. Stretching of ependymal cells in
enlarged ventricles has been observed (Shook et al., 2013), but the
responses of ependymal cells to the disruption of the ependymal
monolayer remain largely unknown. In response to lesion or disruption
of Notch-signaling, ependymal cells in the region of the neurogenic LV
walls can convert into astrocytes and vice versa, confirming that
ependymal-cell characteristics are actively maintained by constitutive
Notch-signaling (Carlen et al., 2009; Nomura et al., 2010). However,
the ependymal-to-astrocyte transition implicated novel GFAP-
expression in the cellular processes (Nomura et al., 2010), which was
not the case in LV-wall adhesion ependymal cells: we did not find co-
existence of GFAP-staining in the cellular processes of PV1 reactive
ependymal cells. However, PV-KO-eGFP ependymal cells in the LV-
wall adhesion did express GFAP (Figure 7d,d2), which might hint at an
alternative mechanism of “activation” when PV is absent from ependy-
mal cells. One explanation for the lower grade of ventricle stenosis
observed in mid-aged PV-KO mice could be a slower progression of
ventricle stenosis caused by insufficient activation or a delay in acquir-
ing the reactive phenotype seen in PV-expressing WT ependymal cells.
Why do ependymal cells upregulate PV? PV is an EF-hand cal-
cium-binding protein known as a slow-onset calcium buffer with high
calcium-binding affinity. PV is abundantly expressed in the brain,
mostly in fast-spiking GABAergic interneurons (Celio, 1986) but also in
long projection neurons (Bilella, Alvarez-Bolado, & Celio, 2016), where
its role is extensively studied, however, very little is known about PV in
other elements of the nervous system. Calcium buffers such as PV are
believed to alter the spatiotemporal aspects of calcium transients
(Schwaller, Meyer, & Schiffmann, 2002). Some calcium-signaling related
mechanisms could also be involved in the case of reactive phenotype
shift seen in ependymal cells, however, the spectrum of biological
processes that are dependent on calcium-signaling are endless. The cell
shape alterations seen in LV-wall adhesion ependymal cells are similar
to those seen in injury-reactive ependymal cells (Szabolcsi & Celio,
2015), therefore, we could assume that PV-upregulation implies similar
processes in the case of LV-wall adhesion ependymal cells as well, such
as cytoskeletal remodeling and cell motility. However, the precise
molecular pathways where PV could interact are yet to be discovered.
In our present study, we demonstrate for the first time an
ependymal-cell response triggered by the fusion of the opposite LV
walls that involves PV-upregulation and reactive phenotype shift in
ependymal cells in the affected regions. PV-positive ependymal cells
seem to contribute to the propagation of adhesion- and fusion-
formation observed throughout aging, based on our observation of
lower ventricle stenosis grade in aging PV-KO mice. The development
of ventricle stenosis associated to severe decline in adult neurogenesis
throughout aging is poorly understood, our study therefore sheds light
on a novel aspect of this biological feature of aging.
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